Myriad Genetics (MYGN) Divestments (2020 - 2021)
Myriad Genetics (MYGN) posted quarterly Divestments of $379.1 million for Q3 2021, up 1679.81% year-over-year from $21.3 million in Q3 2020, and up 1679.81% quarter-over-quarter from $21.3 million in Q3 2020.
Myriad Genetics (MYGN) Divestments (2020 - 2021) Analysis & Trends
Myriad Genetics (MYGN) has reported Divestments for 2 consecutive years, with $379.1 million the latest figure, recorded in Q3 2021.
- In Q3 2021, Divestments rose 1679.81% year-over-year to $379.1 million; the TTM figure through Dec 2024 stood at $379.1 million (changed 0.0% YoY), while the FY2024 annual figure was $8.8 million, changed N/A from the prior year.
- Divestments climbed to $379.1 million in Q3 2021 per MYGN's latest filing, from $21.3 million in the prior quarter.
- Across five years, Divestments topped out at $379.1 million in Q3 2021 and bottomed at -$21.3 million in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | - |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | - |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | - |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | - |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | - |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | - |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | - |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | - |
| 10 | Myriad Genetics | 297.97 Mn | 173.57 Mn | 137.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 379.10 Mn |
| Sep 30, 2020 | 21.30 Mn |
| Jun 30, 2020 | -21.30 Mn |
| Mar 31, 2020 | 21.30 Mn |